Can teaching parents to talk about sex protect LGBTQ teens?
NCT ID NCT07825571
First seen Sep 17, 2026 · Last updated Sep 18, 2026 · Updated 1 time
Summary
Researchers at the University of Pennsylvania are testing a five-session group program called GIST that trains parents of transgender, gender diverse, lesbian, and bisexual female youth to discuss sexuality and health. The trial enrolls 300 parents and their 12- to 18-year-old children in the United States. The study measures how much and how well families communicate about topics like coming out, condom use, and peer pressure, and tracks depression symptoms in both parents and teens.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- a five-session group program that trains parents to talk with their LGBTQ teens about sexuality and health
- What this could lead to
- If it works, this could give families a practical way to talk about sexuality and health, which may help lower HIV and STI risk for LGBTQ youth.
- What could go wrong
- Better parent-teen communication may not translate into lower infection rates, and the trial measures communication and mental health rather than HIV or STI diagnoses. Results may not apply to families outside the United States.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 300 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2026
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
12 to 100 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Youth participants are: identify as transgender or gender diverse, or lebian or bisexual female be between ages 12-18 years able to comprehend spoken English resides in the United States consents or assents to study participation Parent participants are: the parent, legal guardians, legal custodians (hereinafter "parent") of index youth age 18 or older able to comprehend spoken English resides in the United States consents to study participation consents to their child's study participation Exclusion Criteria: Excluded youth participants are: non-transgender or gender diverse or lesbian or bisexual female youth Excluded participants are: parents whose child does not meet eligibility criteria
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Communication about health information are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Penn Nursing
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.